ArticleMolecular biomedicine2026

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Yunjian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.